ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Belgium’s BEL 20 rises 0.11% to one-month high as key sectors advance

The BEL 20 index closed higher on Monday, lifted by gains in consumer services, financials and basic materials. Anheuser-Busch InBev led advancers, while Argen-X led decliners.

PA
Priya Anand · Equities & Earnings Desk · 24 Aug 2026 · 16:21 · 1 min read
Share
Belgium’s BEL 20 rises 0.11% to one-month high as key sectors advance

Belgium’s blue-chip BEL 20 index rose 0.11% to a one-month high at the close of trade on Monday, as gains in consumer services, financials and basic materials offset broader softness in the broader Brussels market.

The index advanced to finish the session at a fresh high for August, according to data from the Brussels bourse. Declining stocks outnumbered advancers by 49 to 42, with 12 issues unchanged.

Among top gainers, Anheuser-Busch InBev SA NV led with a 2.11% rise, adding 1.42 points to close at 68.58. Umicore SA climbed 1.74% to 23.36, while Azelis Corporate Services NV rose 1.69% to 12.04.

The index’s top decliners included Argen-X, which fell 4.19% to 864.20, Melexis NV, which dropped 1.85% to 63.80, and D’Ieteren NV, which slipped 0.95% to 176.60.

Commodities showed mixed performance, with gold futures for December delivery up 0.82% at $4,718.79 per troy ounce. Crude oil futures for October delivery fell 2.56% to $84.83 per barrel, while Brent crude for November delivery declined 2.19% to $90.64 per barrel.

The euro held steady against the dollar, with EUR/USD flat at 1.17, while EUR/GBP was little changed at 0.86. The U.S. Dollar Index futures rose 0.16% to 98.89.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT